跳至主要内容
临床试验/EUCTR2016-004726-42-GB
EUCTR2016-004726-42-GB进行中(未招募)1 期

Randomised controlled trial on the use of synthetic osmotic cervical dilator in induction of labour in comparison to dinoprostone vaginal insert - SOLVE

Birmingham Women's Hospital0 个研究点目标入组 860 人开始时间: 2016年12月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
860

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Women must meet the following criteria prior to initiation of IoL:
  • 1.= 16 years of age
  • 2.Able to provide informed consent
  • 3.Singleton pregnancy
  • 4.Indication for IoL
  • 5.Pregnancy = 37.0 weeks (assessed as an agreed gestational age by ultrasound dating scan at 11-14 weeks)
  • 6.Living fetus with vertex presentation
  • 7.Intact membranes
  • 8.Bishop Score (NICE Modified version July 2008) < 6 points
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 60
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 800
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • 1.Women already receiving oxytocin
  • 2.Diagnosis of fulminant preeclampsia / eclampsia
  • 3.Contraindication to PROPESS or DILAPAN
  • 4.If PROPESS for IoL is non-compliant with local policy
  • 5.Enrolled in other randomised controlled trials of an IMP or device for cervical ripening or induction of labour

研究者

发起方
Birmingham Women's Hospital

相似试验